Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia	B-cell acute lymphoblastic leukemia, B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Tumor Virus Infections, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious disease	Recruiting	Not stated	2024-09-19		NCT06450067

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Juventas Cell Therapy Ltd.	16

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University	Zhengzhou	China	1
Institute of Hematology & Blood Diseases Hospital	Tianjin	China	22
Peking University People's Hospital	Beijing	China	12
Peking University Third Hospital	Beijing	China	21
Qilu Hospital of Shandong University	Jinan	China	68
The Affiliated Hospital of Xuzhou Medical University	Xuzhou	China	28
Tongji Hospital Of Tongji University	Shanghai	China	4
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	54
West China School of Medicine/West China Hospital of Sichuan University	Chengdu	China	3
ZhuJiang Hospital of Southern Medical University	Guangzhou	China	27